Search

Abstract: Hepatitis B virus (HBV) with a C/D recombinant genotype is dominant in Tibet. A rapid, simple and specific genotyping system, consisting of three real-time PCR assays, was developed for the determination of genotypes C and D as well as two forms of recombinant C/D. Overall, 95% of the 22 samples were genotyped accurately. This system is considered to be a useful method for large-scale genotype surveys in Tibet. [Copyright &y& Elsevier]

Apolipoprotein A5 ( APOA5 ) gene plays a key role in plasma triglyceride (TG) metabolism, and shows the involvement in coronary artery disease (CAD). A set of single nucleotide polymorphisms around the APOA5 gene was identified to be associated with plasma TG levels. It is of biological and clinical importance to discern the genuine genetic determinants. A polymorphism in 3′ untranslated region of the APOA5 gene, rs2266788, is deserving of investigation for suggestive clues from the association in multiple independent studies. In this study, rs2266788 was genotyped in 3222 unrelated subjects consisting of 2062 CAD cases and 1160 controls. The statistical analyses indicated that the minor C allele of rs2266788 was significantly associated with elevated plasma TG levels and higher CAD risk. In normal human liver tissues, comparison of global APOA5 mRNA levels among genotypes and allelic expression imbalance analysis showed the decreased gene expression for the C allele. Luciferase assays confirmed a concordant result that transcriptional activity was lowered for the C allele compared with the T allele in four cell lines. Multiple lines of evidence in our study supported that rs2266788 was causally associated with plasma TG levels conferring CAD risk in Han Chinese population owing to a cis -acting effect to the APOA5 gene expression. [ABSTRACT FROM AUTHOR]

[Display omitted] • A sandwich-type electrochemical biosensor for ctDNA detection was designed through facile steps. • The synthesized MWCNTs-PDA-Au-Pt shows excellent catalytic capacity and was used as SPs' label for signal amplification. • The electrochemical biosensor exhibits satisfactory sensitivity for ctDNA detection. • The proposed sandwich-type scheme is a promising method in clinical ctDNA diagnosis. It is of great importance to accurately analyze circulating tumor DNA (ctDNA), for the reason that it serves as one of the particularly informative cancer biomarkers for disease diagnosis, therapy, and prognosis. However, sensitive detection of ctDNA remains a challenging task and the design of feasible sensing method plays a significant role in ctDNA analysis. In this work, a novel sandwich-type electrochemical biosensor was developed through a facile way for sensitive detection of ctDNA using nanocomposites (MWCNTs-PDA-Au-Pt) as signal probes' (SPs) label (SPs-label) for signal amplification. The current response of the nanocomposites towards H 2 O 2 reduction was used to quantitatively detect target DNA and distinguish base-mismatched DNA sequences. Characterizations reveal that Au-Pt alloy nanoparticles are uniformly dispersed on MWCNTs-PDA and the resultant MWCNTs-PDA-Au-Pt shows excellent response toward the reduction of H 2 O 2 , which could largely amplify the current response. Electrochemical analysis of electrode modification process confirms that the sandwich-type structure was successfully formed through step-wise reactions, including fixation of capture probes (CPs) on the surface of the screen-printed gold electrode, recognition between CPs and target DNA (T-DNA), hybridization between T-DNA and SPs. Under optimal experimental conditions, the proposed ctDNA biosensor exhibits a wide linear range from 1 × 10−15 to 1 × 10−8 mol/L with a detection limit as low as 5 × 10−16 mol/L (S/N = 3), unprecedented selectivity towards T-DNA and other base-mismatched DNAs (even for only single base-mismatched sequences), and superb long-term stability. This work demonstrates the sandwich-type scheme is a promising method for practical applications in clinical ctDNA diagnosis. [ABSTRACT FROM AUTHOR]

Summary We comprehensively analyzed clinical, genomic, and transcriptomic data of a cohort of 465 primary triple-negative breast cancer (TNBC). PIK3CA mutations and copy-number gains of chromosome 22q11 were more frequent in our Chinese cohort than in The Cancer Genome Atlas. We classified TNBCs into four transcriptome-based subtypes: (1) luminal androgen receptor (LAR), (2) immunomodulatory, (3) basal-like immune-suppressed, and (4) mesenchymal-like. Putative therapeutic targets or biomarkers were identified among each subtype. Importantly, the LAR subtype showed more ERBB2 somatic mutations, infrequent mutational signature 3 and frequent CDKN2A loss. The comprehensive profile of TNBCs provided here will serve as a reference to further advance the understanding and precision treatment of TNBC. Graphical Abstract Highlights • We build the genomic and transcriptomic landscape of 465 primary TNBCs • Chinese TNBC cases demonstrate more PIK3CA mutations and LAR subtype • Transcriptomic data classify TNBCs into four subtypes • Multi-omics profiling identifies potential targets within specific TNBC subtypes Jiang et al. characterize primary Chinese triple-negative breast cancer (TNBC) and classify it into four subtypes. They find that these TNBCs have more frequent PIK3CA mutations and chromosome 22q11 copy-number gains than non-Asian TNBCs and that the LAR subtype has more ERBB2 somatic mutations and CDKN2A loss. [ABSTRACT FROM AUTHOR]